Mithra Pharmaceuticals SA (MITRA.BR) Stock Cash Flow
Europe - Euronext Brussels - EBR:MITRA - BE0974283153 - Common Stock
0.216 EUR
0 (-1.82%)
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.93M | -26.25M | -87.88M | -83.68M | 34.97M | |||
| Depreciation Amortization | 12.27M | 11.94M | 10.43M | 9.77M | 5.78M | |||
| Change In Working Capital | 26.78M | -31.45M | 6.15M | -11.45M | -52.63M | |||
| Interest Paid | 10.32M | 9.86M | 11.77M | 3.50M | 3.32M | |||
| Taxes Paid | N/A | 322.00K | N/A | 0.00 | -359.00K | |||
| Other non cash items | -9.50M | -11.06M | -3.09M | 5.34M | -34.95M | |||
| OPERATING CASH FLOW | -9.38M | -56.82M | -74.39M | -80.03M | -46.83M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -18.96M | -25.66M | -21.18M | -16.23M | -15.46M | |||
| Other Investing Activity | 7.96M | 168.00K | -33.50M | 23.00K | -5.00M | |||
| INVESTING CASH FLOW | -11.01M | -25.49M | -54.68M | -16.21M | -20.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 22.79M | 52.43M | 26.56M | -4.35M | -6.25M | |||
| Stock Issued/Repurchased | 3.67M | 36.37M | 9.21M | 65.73M | 170.00K | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | -11.48M | -10.93M | -12.53M | 123.81M | 4.13M | |||
| FINANCING CASH FLOW | 14.97M | 77.87M | 23.25M | 185.19M | -1.95M | |||
| Exchange Rate Effect | -174.00K | -147.00K | 21.00K | N/A | N/A | |||
| CHANGE IN CASH | -5.58M | -4.59M | -105.80M | 88.96M | -69.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.38M | -56.82M | -74.39M | -80.03M | -46.83M | |||
| Capital Expenditure | -18.96M | -25.66M | -21.18M | -16.23M | -15.46M | |||
| FREE CASH FLOW | -28.34M | -82.48M | -95.57M | -96.26M | -62.28M | |||
All data in EUR